These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8693298)

  • 1. [Beta-blockers in cardiac insufficiency. Time to reconsider?].
    Follath F
    Schweiz Med Wochenschr; 1996 May; 126(18):747-9. PubMed ID: 8693298
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blockers and reverse remodeling: what are the implications?
    Francis GS; Tang WH
    Am Heart J; 2003 Feb; 145(2):200-2. PubMed ID: 12595832
    [No Abstract]   [Full Text] [Related]  

  • 3. [Beta-blocker therapy for chronic heart failure in patients with dilated cardiomyopathy].
    Hori M; Kagiya T; Sato H; Kitabatake A
    Kokyu To Junkan; 1990 Dec; 38(12):1203-9. PubMed ID: 1981100
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of beta-blockers in the pharmacologic treatment of congestive heart failure].
    Longo A
    Rev Port Cardiol; 1989; 8(7-8):563-8. PubMed ID: 2576636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Beta blockers in heart insufficiency].
    Noll G
    Praxis (Bern 1994); 1995 Mar; 84(11):313-8. PubMed ID: 7724947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers in elderly patients with heart failure ready for prime time?
    Lainscak M; Duengen HD; Anker SD
    J Am Coll Cardiol; 2009 Dec; 54(23):2202. PubMed ID: 19942096
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adrenergic beta-blockaders in the treatment of congestive heart failure].
    Longo A
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():53-9, 9. PubMed ID: 7904459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
    Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NMR shows how beta blockers change the failing ventricle. Decreased size and better output performance].
    MMW Fortschr Med; 2003 Jun; 145(25):56. PubMed ID: 12891860
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta blockers in systolic heart failure: do physicians need more courage?
    Yilmaz MB; Refiker M
    Am Heart J; 2007 Nov; 154(5):e23; author reply e25. PubMed ID: 17967570
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
    Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
    Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of beta-blockers in dilated cardiomyopathy.
    Waagstein F
    Curr Opin Cardiol; 1995 May; 10(3):322-31. PubMed ID: 7612984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
    De Maria R; Di Lenarda A; Gavazzi A; Porcu M; Sinagra G; Parolini M;
    Ital Heart J; 2001 Feb; 2(2):130-8. PubMed ID: 11256541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which beta-blocker for heart failure?
    Adams KF
    Am Heart J; 2001 Jun; 141(6):884-8. PubMed ID: 11376299
    [No Abstract]   [Full Text] [Related]  

  • 18. Surrogate end points in heart failure trials.
    Gheorghiade M; Adams KF; Gattis WA; Teerlink JR; Orlandi C; O'Connor CM
    Am Heart J; 2003 Feb; 145(2 Suppl):S67-70. PubMed ID: 12594457
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
    Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI
    Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.